Oxford Immunotec Announces National Reimbursement For The T-SPOT®.TB Test In France OXFORD, United Kingdom and MARLBOROUGH, Mass., June 22, 2017 (GLOBE NEWSWIRE) — Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on...
Kyruus Enhances Its Clinical Leadership with New Chief Medical Officer, Erin Jospe, M.D. Boston, MA – Kyruus, a leader in provider search and scheduling solutions for health systems, announced today that Erin Jospe, M.D., has joined its leadership team as the...
Oxford Immunotec Announces Favorable Claim Construction Ruling in Patent Infringement Litigation OXFORD, United Kingdom and MARLBOROUGH, Mass., June 15, 2017 (GLOBE NEWSWIRE) — Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company...
Neuronetics, Inc. Raises $15 Million in Series G Equity Financing, Led by Ascension Ventures Capital will help expand clinical adoption of NeuroStar® Advanced Therapy, the company’s market-leading transcranial magnetic stimulation (TMS) treatment MALVERN,...
AbbVie and Principia Annouce Collaboration on Oral Immunoproteasome Inhibitors NORTH CHICAGO, Ill. and SOUTH SAN FRANCISCO, Calif., June 13, 2017 – AbbVie (NYSE: ABBV), a global biopharmaceutical company, and Principia Biopharma Inc., a private, clinical-stage...
Recent Comments